Accepted at 4:20 a.m. Nov, 01, 2023 by Ahmed7
Author: emgleason
Co-authors: Ahmed7
Related Note: 1579822414309 1
Rationale for change

The original card didn't talk about frequency of dosing
Source: Society Guidelines - https://www.cdc.gov/tb/publications/ltbi/pdf/LTBIbooklet508.pdf

Text Text
Extra Extra
Lecture Notes
Empty field
Missed Questions
Empty field
Pathoma
Empty field
Boards and Beyond
Empty field
First Aid
Sketchy
Sketchy 2
Empty field
Sketchy Extra
Picmonic
Empty field
Pixorize
Empty field
Physeo
Bootcamp
OME
Additional Resources
Empty field
One by one
Empty field
#AK_Other::Only_Step_1&2_Overlap #AK_Step1_v12::#FirstAid::03_Microbiology::07_Antimicrobials::26_Antituberculous_drugs::*Isoniazid #AK_Step2_v12::#AMBOSS::IQ0Yxf #AK_Step2_v12::#OME::01_Medicine::06_Infectious_Disease::03_TB #AK_Step2_v12::Original_decks::Dorian::im::ome::infection::tb #AK_Other::AnKing_Image::!Subjects::Pulmonology::Pulmonary_Tuberculosis #AK_Step2_v12::#FirstAid::14_Pulm::07_Mycobacterial_Infections::01_Tuberculosis #AK_Step1_v12::#FirstAid::03_Microbiology::07_Antimicrobials::27_Antimycobacterial_therapy #AK_Step3_v12::#UWorld::13189 #AK_Step1_v12::#NinjaNerd::03_Microbiology::04_Pharmacology::01_Antimycobacterials #AK_Step1_v12::#Bootcamp::Microbiology::08_Mycobacteria::04_Pulmonary_Tuberculosis_Diagnostics_And_Management #PANCE::EOR::Family_med #AK_Step3_v12::#UWorld::5234 #AK_Step3_v12::#UWorld::5504 #PANCE::PULM::infectious_disorders #AK_Step1_v12::#SketchyPharm::07_Antimicrobials::03_Antimycobacterials::01_Tuberculosis_Drugs #AK_Step2_v12::#Resources_by_rotation::IM::ome::infection::tb #AK_Step2_v12::Original_decks::Dorian::fam::amboss #AK_Step2_v12::#Subjects::Microbiology::01_Bacteria::08_Mycobacteria::Mycobacterium_Tuberculosis::Management #AK_Other::AnKing_Image::AhmedA::Pulmonary_Tuberculosis #AK_Step2_v12::#B&B::08_Infectious_Disease::04_Other::04_Tuberculosis::Extra #AK_Step2_v12::#NBME::Form14::Section_1 #AK_Step2_v12::#Bootcamp::Pediatrics::03_Infectious_Disease::02_Airway_and_Respiratory_Infections::06_Tuberculosis #AK_Step1_v12::#Physeo::06_Micro::02_Bacteria::41_Mycobacterium_Tuberculosis #AK_Other::#AK_Original_Decks::Step_2::Cheesy_Dorian_(M3) #AK_Step3_v12::#UWorld::6167 #AK_Step2_v12::#NBME::Form16::Section_2 #AK_Step2_v12::#AMBOSS::Ip0YIS #AK_Step1_v12::#Bootcamp::Microbiology::36_Antibiotics::22_Isoniazid #AK_Step2_v12::#OME::Clinical::Internal_Medicine::Infectious_Disease::Tuberculosis: #AK_Step1_v12::#Physeo::^physeo_image_update #AK_Step2_v12::#AMBOSS::1va2_m #AK_Step1_v12::#Physeo::09_Pharm::05_Antibiotics::23_Isoniazid_(RIPE)